Insight into genetic diversity of Mycobacterium tuberculosis in Kandy, Sri Lanka reveals predominance of the Euro-American lineage.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 17 05 2019
revised: 24 06 2019
accepted: 01 07 2019
pubmed: 13 7 2019
medline: 18 12 2019
entrez: 13 7 2019
Statut: ppublish

Résumé

Sri Lanka is a country where the molecular epidemiology of Mycobacterium tuberculosis (MTB) is poorly explored. Therefore, this study was performed to identify circulating lineages/sub-lineages of MTB and their transmission patterns. DNA was extracted from 89 isolates of MTB collected during 2012 and 2013 from new pulmonary tuberculosis patients in Kandy, Sri Lanka and analyzed by spoligotyping, large sequence polymorphism (LSP), mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing, and drug resistance-associated gene sequencing. The predominant lineage was lineage 4 (Euro-American, 45.9%), followed by lineage 1 (Indo-Oceanic, 29.4%), lineage 2 (East-Asian, 23.5%), and lineage 3 (Central-Asian, 1.2%). Among 26 spoligotype patterns, eight were undesignated or new types and seven of these belonged to lineage 4. Undesignated lineage 4/SIT124 (n=2/8) and SIT3234 (n=8/8) clustered together based on 24-locus MIRU-VNTR typing. The dominant sub-lineage was Beijing/SIT1 (n=19), with the isoniazid resistance katG G944C mutation (Ser315Thr) detected in two of them. The population structure of MTB in Kandy, Sri Lanka was different from that in the South Asian region. The clonal expansion of locally evolved lineage 4/SIT3234 and detection of the pre-multidrug resistant Beijing isolates from new tuberculosis patients is alarming and will require continuous monitoring.

Identifiants

pubmed: 31299365
pii: S1201-9712(19)30276-0
doi: 10.1016/j.ijid.2019.07.001
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Isoniazid V83O1VOZ8L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-91

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Charitha Mendis (C)

Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan; Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Peradeniya, Sri Lanka.

Vasanthi Thevanesam (V)

Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka.

Athula Kumara (A)

Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka.

Susiji Wickramasinghe (S)

Department of Parasitology, Faculty of Medicine, University of Peradeniya, Sri Lanka.

Dushantha Madegedara (D)

Respiratory Disease Treatment Unit, Teaching Hospital, Kandy, Sri Lanka.

Chandika Gamage (C)

Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka.

Stephen V Gordon (SV)

School of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland; Global Station for Zoonosis Control, Hokkaido University Global Institute for Collaborative Research and Education, Sapporo, Japan.

Yasuhiko Suzuki (Y)

Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan; Global Station for Zoonosis Control, Hokkaido University Global Institute for Collaborative Research and Education, Sapporo, Japan.

Champa Ratnatunga (C)

Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka. Electronic address: medmicropera@pdn.ac.lk.

Chie Nakajima (C)

Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan; Global Station for Zoonosis Control, Hokkaido University Global Institute for Collaborative Research and Education, Sapporo, Japan. Electronic address: cnakajim@czc.hokudai.ac.jp.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH